Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
LENZ holding history
LENZ Therapeutics, Inc. in every 13F filed by Prosight Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LENZ overviewAll 13F holders of LENZFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −59,542−100.0% | Sold out | Holders |
| Q2 2024 | 59,542 | $1.03M | 0.3% | −5,458−8.4% | Reduced | Holders |
| Q1 2024 | 65,000 | $1.45M | 0.4% | −128,134−66.3% | ReducedConverted for a 1-for-7 split | Holders |
| Q4 2023 | 1,351,939 | $3.54M | 1.4% | +14,113+1.1% | Added | Holders |
| Q3 2023 | 1,337,826 | $3.32M | 1.1% | −362,174−21.3% | Reduced | Holders |
| Q2 2023 | 1,700,000 | $4.42M | 1.3% | +823,334+93.9% | Added | Holders |
| Q1 2023 | 876,666 | $2.15M | 1.0% | −39,892−4.4% | Reduced | Holders |
| Q4 2022 | 916,558 | $3.04M | 1.7% | +560,113+157.1% | Added | Holders |
| Q3 2022 | 356,445 | $1.13M | 0.6% | +356,445 | New | Holders |